Mark Blumenkranz

Executive Chairman, Co-Founder, and CEO at Kedalion Therapeutics · Previously invested at Lagunita BioSciences

Investments

Lead Investments

Menlo Park, California, United States, US

Highlights

Focus Areas

Biotechnology

Health Care

Therapeutics

Medical

Firms Invested Under

Recent Investments